Which β-
or islet-cell-specific targets will be most useful for a variety of studies,
including imaging, small molecule delivery, and immune targeting efforts (e.g.,
CAR-Treg, therapeutic antibodies)?
Please provide answers to the questions below to contribute ideas/suggestions towards this new nPOD Working Group. Many thanks, Roberto and Qizhi